US Health Insurers Face Rising Costs as Prior Authorization Reforms Stall

Deep News12-04 23:02

A recent industry survey reveals that major US health insurers including UnitedHealth (UNH), The Cigna Group (CI), Humana (HUM), CVS Health (CVS), and Elevance Health (ELV) are grappling with mounting costs, increased regulatory scrutiny, and investor concerns. Simultaneously, healthcare provider groups report that promised reforms to prior authorization processes have yet to materialize.

The findings highlight growing challenges in the health insurance sector as companies balance cost pressures with regulatory compliance and operational efficiency. Medical providers continue to voice frustrations over administrative burdens associated with prior authorization requirements, despite industry pledges to streamline these processes.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment